GSK partners with ABB to work towards net-zero targets
ABB will upgrade legacy motors at GSK's vaccine manufacturing facility in Tuas South, Singapore. Through the move, GSK is projected to reduce CO2 emissions by 246 tonnes and lower energy costs by $130,000